Most of us have heard of heart, liver and kidney transplants. But not many know about poop transplant or Faecal microbiota ...

FDA Approves Orphan Drug Fidaxomicin for Pediatric CDI The FDA has granted orphan drug designation for all formulations of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted ...

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative therapeutic strategies to antibiotics and fecal transplant. To investigate whether ...

A 70-year-old woman with a history of Clostridium difficile infection returned to the clinic with abdominal pain and diarrhea. Three stool samples were negative for C. difficile and WBCs. Would you ...

Transplanting faecal matter from one person to another — the thought might turn your stomach, but it could be lifesaving. Some doctors are using the procedure to repopulate the gut with healthy ...

Clostridioides difficile infection (CDI) arises predominantly in healthcare settings following antibiotic-mediated disruption of the gut microbiota. Patients may present a spectrum from asymptomatic ...

Clostridioides difficile is a notoriously nasty intestinal bug, with few effective treatments and no approved vaccines. But the same technology that enabled the first COVID-19 vaccines has shown early ...

Clostridium difficile (C. diff) can cause diarrhea, stomach pain, nausea, and fever. About 1 in 6 people get a second infection within weeks. C. diff is most common in people taking antibiotics, since ...

Clostridium difficile infection (CDI) is considered to be the main cause of bacterial infectious diarrhea in nosocomial settings. Since the beginning of the new century a continuous rise in the ...